Abstract
Dapsone given over 14 weeks in a dose of 50 mg a day for 1 week and thereafter 100 mg a day was found to have a beneficial effect in rheumatoid arthritis when compared with placebo administration to a matched group of patients. Significant improvement in 5 out of 7 clinical measurements and in erythrocyte sedimentation rate, viscosity, C-reactive protein was found in those patients taking dapsone. There was significant improvement compared to the placebo group in 2 out of the 7 clinical measurements and again in all 3 acute-phase reactants. The drug was quite well tolerated over the 14-week duration of the trial. The tendency to cause haemolysis will be its main limiting factor as a practical alternative to other suppressive agents currently in use.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnetson R. S., Pearson J. M., Rees R. J. Evidence for prevention of borderline leprosy reactions by dapsone. Lancet. 1976 Nov 27;2(7996):1171–1172. doi: 10.1016/s0140-6736(76)91684-6. [DOI] [PubMed] [Google Scholar]
- Barranco V. P. Inhibition of lysosomal enzymes by dapsone. Arch Dermatol. 1974 Oct;110(4):563–566. [PubMed] [Google Scholar]
- Dyer N. H., Kendall M. J., Hawkins C. F. Malabsorption in rheumatoid disease. Ann Rheum Dis. 1971 Nov;30(6):626–630. doi: 10.1136/ard.30.6.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellis B. P. Leprosy and the rheumatoid factor. Cent Afr J Med. 1978 Jan;24(1):8–10. [PubMed] [Google Scholar]
- Green F. H., Carty J. E. Letter: Coeliac disease and autoimmunity. Lancet. 1976 May 1;1(7966):964–964. doi: 10.1016/s0140-6736(76)92742-2. [DOI] [PubMed] [Google Scholar]
- Lewi P. J., Symoens J. Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study. J Rheumatol Suppl. 1978;4:17–25. [PubMed] [Google Scholar]
- McConkey B., Davies P., Crockson R. A., Crockson A. P., Butler M., Constable T. J., Amos R. S. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis. 1979 Apr;38(2):141–144. doi: 10.1136/ard.38.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McConkey B., Davies P., Crockson R. A., Crockson A. P., Butler M., Constable T. J. Dapsone in rheumatoid arthritis. Rheumatol Rehabil. 1976 Aug;15(3):230–234. doi: 10.1093/rheumatology/15.3.230. [DOI] [PubMed] [Google Scholar]
- Ognibene A. J. Agranulocytosis due to dapsone. Ann Intern Med. 1970 Apr;72(4):521–524. doi: 10.7326/0003-4819-72-4-521. [DOI] [PubMed] [Google Scholar]
- Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]